Share buyback program of up to USD 1.2 billion
LUXEMBOURG, May 27, 2025 (GLOBE NEWSWIRE) — Tenaris S.A. (NYSE and Mexico: TS and EXM Italy: TEN) ('Tenaris') announced today that Tenaris's Board of Directors approved a share buyback program of up to $1.2 billion (which, at the closing price of May 27, 2025 on the Milan Stock Exchange would represent approximately 74 million shares, or 6.9% of Tenaris's outstanding shares), to be executed within a year, with the intention to cancel the ordinary shares acquired through the program.
The decision and opportunity of initiating the buyback program is driven by the company's significant cash flow generation and strong balance sheet.
The buyback program will be carried out under the authority granted by the annual general meeting of shareholders held on May 6, 2025, up to a maximum of 10% of the Company´s shares.
The buyback program is expected to be launched in June 2025 and share purchases will be executed through a primary financial institution.
The buybacks may be ceased, paused and continued at any time, subject to compliance with applicable laws and regulations.
Tenaris will provide updates on the buyback program via press releases and on the Investors section of its corporate website. The buybacks will be carried out subject to market conditions and in compliance with applicable laws and regulations, including the Market Abuse Regulation 596/2014 and the Commission Delegated Regulation (EU) 2016/1052.
Some of the statements contained in this press release are 'forward-looking statements'. Forward-looking statements are based on management's current views and assumptions and involve known and unknown risks that could cause actual results, performance or events to differ materially from those expressed or implied by those statements. These risks include but are not limited to risks arising from uncertainties as to future oil and gas prices and their impact on investment programs by oil and gas companies.
Tenaris is a leading global supplier of steel tubes and related services for the world's energy industry and certain other industrial applications.
Giovanni Sardagna Tenaris1-888-300-5432
www.tenaris.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
22 minutes ago
- Yahoo
Scooter Market Report 2025 with Long-term Forecast to 2034: Smart Connected Scooters Transform Commuter Experience with Advanced Features
By 2034, the global scooter market is set to reach USD 143.1 billion, growing at a CAGR of 8.1% from 2025's USD 70.8 billion. Rising demand for electric scooters, driven by environmental concerns and policy support, is key. Asia-Pacific leads, with e-commerce growth and smart connectivity boosting adoption globally. Scooter Market Dublin, June 12, 2025 (GLOBE NEWSWIRE) -- The "Scooter Market 2025-2034" has been added to offering. The global scooter market, valued at USD 70.8 billion in 2025, is projected to grow to USD 143.1 billion by 2034, at a CAGR of 8.1% This dynamic segment in the personal mobility industry is gaining traction due to its cost-effective and energy-efficient solutions for urban environments. The market is flourishing with both traditional internal combustion engine scooters and a rapidly growing array of electric scooters (e-scooters), responding to climate concerns and legislative efforts for sustainable transport. In the Asia-Pacific region, the sector thrives on urban expansion, rising incomes, and limited public transit options. Western markets see a surge in electric kick scooters and shared mobility models, appealing to eco-conscious millennials and Gen Z. Evolving consumer preferences are shaped by features like connected dashboards and app-based controls. With fluctuating fuel prices and sustainable policies, scooters offer affordability, agility, and reduced emissions for various uses. In 2024, market growth accelerated, emphasizing electric models and favorable government initiatives on emissions and congestion. Countries enacted subsidies and infrastructure improvements, enhancing electric scooter sales in India, China, and Europe. Manufacturers advanced lithium-ion batteries, optimizing range and charging times, and explored swappable battery models to ease infrastructure burdens. Smart scooter adoption rose, featuring app-based navigation, anti-theft systems, and real-time diagnostics. Commercial entities expanded their fleets, capitalizing on economic benefits, and cities managed shared operations to enhance safety. Lightweight, foldable scooters gained popularity for their practicality. In 2024, scooters solidified their position in urban mobility amid efficiency and environmental imperatives. Looking ahead, the market is projected to pivot towards electrification, autonomy, and connectivity, transforming mobility, particularly in dense populations. Investment in battery technology promises enhanced electric scooters. AI and IoT integration will improve predictive maintenance, diagnostics, and analytics. Regulatory mandates will likely accelerate the phasing out of ICE scooters, especially in urban zones. E-commerce and food deliveries will boost demand for commercial models with telematics and cargo customization. Subscription ownership models and MaaS platforms will expand market penetration by offering flexible plans. Developing regions will see robust growth as local manufacturing and supply chains mature. Premium segments will expand, delivering high-performance scooters with advanced features. As smart mobility gains emphasis, scooters will sustain their role in sustainable transport, enabling efficient and eco-friendly urban commuting. Key Insights Rising demand for e-scooters with swappable batteries, enhancing convenience and reducing charging infrastructure reliance. Smart connectivity, including app controls and real-time navigation, attracts tech-savvy users. Demand increases for lightweight and foldable designs suitable for integrated transport use. Shared micro-mobility services utilizing IoT for fleet optimization drive urban scooter usage. Design aesthetics and rider comfort spur innovative, stylistic changes. Government incentives make electric scooters more accessible, driving adoption. Environmental awareness boosts preference for zero-emission models. Key Attributes: Report Attribute Details No. of Pages 150 Forecast Period 2025 - 2034 Estimated Market Value (USD) in 2025 $70.8 Billion Forecasted Market Value (USD) by 2034 $143.1 Billion Compound Annual Growth Rate 8.1% Regions Covered Global Companies Featured Yadea Technology Group Co. Ltd. Ninebot Limited Neutron Holdings Inc. Bird Rides Inc. Skinny Labs Inc. Honda Motor Co. Ltd. Yamaha Motor Pvt. Ltd. Harley-Davidson Inc. Piaggio & C SpA Suzuki Motor Corporation Bayerische Motoren Werke AG. Hero MotoCorp Ltd. Bajaj Auto Ltd. TVS Motor Company Ltd. Mahindra & Mahindra Ltd. Ducati Motor Holding SpA Triumph Motorcycles Ltd. Kawasaki Heavy Industries Ltd. Sanyang Motor Co. Ltd. Gogoro Inc. NIU Technologies Segway Inc. Razor USA LLC Okinawa Autotech Pvt. Ltd. Ather Energy Pvt. Ltd. Ampere Electric Vehicles Pvt Ltd. Revolt Intellicorp Pvt. Ltd. Ola Electric Mobility Pvt. Ltd. Zhongneng Vehicle Group Co. Ltd. Baotian Motorcycle Industrial Co. Ltd. Bashan Motorcycle Manufacturing Co. Ltd For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Scooter Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
24 minutes ago
- Yahoo
Opinion: It's Time to Buy UnitedHealth Group Stock After a 50% Plunge
Most of UnitedHealth Group's issues should be temporary. The two biggest threats to the healthcare giant are iffy. The price is right to buy UnitedHealth Group stock after its steep decline. 10 stocks we like better than UnitedHealth Group › UnitedHealth Group (NYSE: UNH) might want to change its stock ticker from "UNH" to "UGH." The latter better captures the feelings of the healthcare giant's shareholders in recent months. A string of problems has caused UnitedHealth Group's share price to plunge roughly 50% from the peak set in the fourth quarter of 2024. Some analysts have downgraded the stock, with HSBC recommending that investors reduce their holdings and slashing its price target. I have a different opinion, though. I think it's time to buy UnitedHealth Group stock. Here are three reasons why. I don't think investors should ignore UnitedHealth Group's issues. However, the challenges should be viewed with a long-term perspective. I suspect most of the problems the company faces should be temporary. UnitedHealth Group has already largely moved past the cyberattack that occurred in February 2024. Although it cost the healthcare company over $2 billion, that issue has already proven to be a short-lived one. Higher Medicare Advantage costs are the main culprit behind UnitedHealth Group's suspension of its 2025 full-year guidance. But the company says that it expects to return to growth in 2026. I believe this prediction because it makes sense. Insurers sometimes incur higher-than-anticipated costs and feel the pain for a while. However, once they adjust premiums, the problem goes away. UnitedHealth Group announced the sudden departure of former CEO Andrew Witty at the same time it withdrew its 2025 outlook. Any worries investors might have had surrounding this move probably dissipated quickly after they learned Stephen Hemsley was returning to run the company. Hemsley served as CEO from 2006 through 2017, a period when UnitedHealth Group stock more than tripled. I also view the two biggest threats to UnitedHealth Group as iffy. What are those threats? An alleged U.S. Department of Justice criminal investigation of the company and President Trump's stated goal to eliminate pharmacy benefits managers (PBMs). Noted that I used the word "alleged" to describe the U.S. Department of Justice probe. The Wall Street Journal reported on May 14, 2025, that "people familiar with the matter" revealed that the DOJ had launched a criminal investigation of UnitedHealth Group for possible Medicare fraud. However, the company quickly responded that it hadn't been notified of any DOJ investigation. That status hasn't changed. President Trump did announce that he wants to "cut out the middleman," a clear reference to PBMs. That's easier said than done, though, to put it mildly. Removing PBMs from the U.S. healthcare system would require a detailed, comprehensive plan that so far has not been provided. That plan would also have to pass in both the Senate and the House of Representatives. You can bet that the PBM industry, including UnitedHealth Group, would lobby fiercely against any such legislation. I think this threat, while serious, has a relatively low probability of actually materializing. Finally, I think all these issues are fully baked into UnitedHealth Group's share price. The stock currently trades at a forward price-to-earnings ratio of around 13.3. That's well below the S&P 500 healthcare sector forward earnings multiple of 16.6. It's also the lowest valuation for UnitedHealth Group in more than a decade. Could the stock fall further? Maybe, but I believe that UnitedHealth Group's share price has bottomed out. You might have noticed that UnitedHealth Group's share price has traded in a relatively narrow range since the steep decline in April and May. This trading pattern seems to confirm my view. Any good news for UnitedHealth Group could provide a nice catalyst. I predict that the company will have some positive developments in the not-too-distant future, potentially including new full-year guidance that calms investors. If I'm right, buying UnitedHealth Group stock now could pay off handsomely. Before you buy stock in UnitedHealth Group, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and UnitedHealth Group wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $649,102!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $882,344!* Now, it's worth noting Stock Advisor's total average return is 996% — a market-crushing outperformance compared to 174% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 9, 2025 HSBC Holdings is an advertising partner of Motley Fool Money. Keith Speights has no position in any of the stocks mentioned. The Motley Fool recommends HSBC Holdings and UnitedHealth Group. The Motley Fool has a disclosure policy. Opinion: It's Time to Buy UnitedHealth Group Stock After a 50% Plunge was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
24 minutes ago
- Yahoo
2 Unstoppable Stocks to Consider Buying, Even Amid Market Volatility
Netflix has a solid plan to become a trillion-dollar company by 2030. Veeva Systems still has a massive addressable market. 10 stocks we like better than Netflix › Broader equities have not performed particularly well in 2025. The S&P 500 is barely in the black year to date. However, considering it hovered near bear market territory a few weeks ago, things aren't so bad. Stocks might not be out of the woods, though. Economic issues could arise, sending markets down, as the Trump administration continues to implement its trade agenda. That said, regardless of what happens on that front, there are plenty of companies worth investing in. Here are two great examples: Netflix (NASDAQ: NFLX) and Veeva Systems (NYSE: VEEV). Netflix, a streaming specialist, has been grabbing headlines recently for all the right reasons. The stock is up for the year, financial results have been good, and management sees significant upside ahead. The company has plans to join the exclusive club of trillion-dollar stocks by 2030. From its current market cap of $522 billion, that will require a compound annual growth rate of 13.9%. That's nothing to sneeze at, but it's well within the company's reach, in my view. Five years ago, Netflix ended 2019 with $20.2 billion in revenue. Last year, that had risen to $39 billion -- a compound annual growth rate (CAGR) of 14.1%. True, a lot has changed since. There is more competition in the streaming field, for instance. Even so, Netflix has made changes that have kept it in the lead in the industry, including a crackdown on password sharing and the introduction of a low-priced ad-supported tier. The company doesn't grow its revenue quite as fast as it used to, but in the past five years, profits and free cash flow have soared. Meanwhile, there is still considerable room for growth in the streaming industry. Netflix's estimate of a $650 billion revenue opportunity reflects the fact that streaming still has yet to completely overtake entertainment. The industry's penetration should expand over the long run and benefit Netflix, considering its strong position, network effect, and brand name. Furthermore, it is increasingly using artificial intelligence (AI) to enhance its content strategy, which is already a key to its success. Though AI won't be the center of Netflix's universe, it can allow the company to make better movies for less money, something that will make a difference down the road. So the goal to achieve a trillion-dollar valuation in the next five years isn't just a pipe dream -- it is well within the company's powers. Even if it fails, though, the stock should deliver superior returns well beyond 2025. Veeva Systems isn't the biggest player in the cloud industry. That title arguably goes to Amazon, with other tech giants, such as Alphabet and Microsoft, not far behind. However, Veeva Systems is a leader in a niche within the industry. It offers cloud solutions primarily to life science companies such as drugmakers. The fact that the company's list of clients features some of the largest pharmaceutical players, including Merck, Novo Nordisk, and Eli Lilly, is telling. The company is doing something right. Here's what that thing is: It has developed a wealth of cloud services specifically catered to the stringent regulatory (and other) demands of the industry. Generic solutions won't do for many of these companies. Enter Veeva Systems. The cloud computing specialist's financial results also reflect its success. Revenue and earnings have been growing at a good clip. And when management set revenue goals to be achieved by a certain date in the past, Veeva has met the goal. It recently hit its $3 billion revenue run-rate target -- which, in 2019, it said it would achieve by the calendar year 2025. That's a management team investors can trust. Many CEOs overpromise and underdeliver. Meanwhile, Veeva still has plenty of white space ahead, with an estimated $20 billion addressable market. Revenue over the trailing-12-month period is $2.9 billion. Given the high switching costs, the company should remain a strong player in this niche for some time as it continues to make headway in its market. It could encounter some headwinds if the economy tanks, as it did a couple of years ago. But the company has recovered nicely since -- a microcosm of what its performance might look like over the long run. Even with occasional slowdowns, expect Veeva Systems to deliver above-average returns in the next decade. Before you buy stock in Netflix, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Netflix wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $649,102!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $882,344!* Now, it's worth noting Stock Advisor's total average return is 996% — a market-crushing outperformance compared to 174% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 9, 2025 John Mackey, former CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool's board of directors. Suzanne Frey, an executive at Alphabet, is a member of The Motley Fool's board of directors. Prosper Junior Bakiny has positions in Amazon, Eli Lilly, and Novo Nordisk. The Motley Fool has positions in and recommends Alphabet, Amazon, Merck, Microsoft, Netflix, and Veeva Systems. The Motley Fool recommends Novo Nordisk and recommends the following options: long January 2026 $395 calls on Microsoft and short January 2026 $405 calls on Microsoft. The Motley Fool has a disclosure policy. 2 Unstoppable Stocks to Consider Buying, Even Amid Market Volatility was originally published by The Motley Fool
